Table 4.
Main clinical characteristics of the six COVID-19 patients who developed superimposed infections.
| Patient | #1 | #2 | #3 | #4 | #5 | #6 |
|---|---|---|---|---|---|---|
| Age (years) | 89 | 88 | 88 | 82 | 28 | 86 |
| Sex | Male | Female | Female | Male | Female | Male |
| Length of stay (days) | 16 | 18 | 28 | 25 | 42 | 4 |
| Site of isolation | Urine | Urine | Urine | Skin | Urine, blood | Urine |
| Microorganism(s) | E. coli | E. faecalis | E. coli, C. glabrata | S. aureus | E. faecalis | E. faecalis |
| Sepsis | No | Yes | No | Yes | Yes | Yes |
| Total lymphocytes (n/µl) | 963.0 | 829.5 | 582.5 | 1148.4 | 767.4 | 1022.5 |
| Total B cells (n/µl) | 27.9 | 145.1 | 41.9 | 28.7 | 55.2 | 71.5 |
| Memory B cells (n/µl) | 19.6 | 46.3 | 26.6 | 6.3 | 3.9 | 42.7 |
| IgM memory B cells (n/µl) | 6.4 | 7.9 | 9.7 | 1.8 | 1.6 | 1.5 |
| Switched memory B cells (n/µl) | 10.7 | 30.1 | 13.9 | 4.5 | 1.8 | 15.0 |
| Platelet-to-lymphocyte ratio | 0.23 | 0.51 | 0.34 | 0.22 | 0.23 | 0.21 |
| Neutrophil-to-lymphocyte ratio | 7.69 | 14.41 | 18.81 | 2.92 | 2.84 | 6.27 |
| Lactate dehydrogenase (mU/ml) | 170 | 217 | 330 | 251 | 250 | 637 |
| C reactive protein (mg/dl) | 15.5 | 13.5 | 7.2 | 3.2 | 3.7 | 19.1 |
| Pitted red cells (%) | 3.4 | 3.7 | 2.3 | 0.06 | 4.2 | 5.0 |
| Platelets (× 103/µl) | 223 | 425 | 197 | 249 | 179 | 218 |
| Outcome | Discharged | Dead | Discharged | ICU | Discharged | Dead |
ICU intensive care unit.